Trials / Completed
CompletedNCT01426308
Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (actual)
- Sponsor
- Illumina, Inc. · Industry
- Sex
- All
- Age
- 1 Minute
- Healthy volunteers
- Accepted
Summary
The study will determine the performance of the Infinium HD Test. * The primary objective of the study is to assess the performance of the Infinium HD Test using banked DNA samples extracted from whole blood patient samples derived from the intended use population. * The secondary objective of the study is to determine the background number of chromosomal abnormalities per person in the general population based on the resolution of the Infinium HD Test.
Conditions
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2011-08-31
- Last updated
- 2016-04-28
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01426308. Inclusion in this directory is not an endorsement.